ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Recombinant Anti-IL-1F7 Antibody [B-F43] (Biotin) (A342236)

Recombinant mouse monoclonal [B-F43] IVD antibody to IL-1F7 (Biotin) for ELISA.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 10-14 business days.
Name
Anti-IL-1F7 Antibody [B-F43] (Biotin)
Description
Recombinant mouse monoclonal [B-F43] IVD antibody to IL-1F7 (Biotin).
Specificity
This product recognizesboth natural and recombinant IL-23, p19 sub-unit.
Applications
ELISA
Reactivity
Human
Immunogen
Recombinant IL-23 (sub-unit p19).
Host
Mouse
Clonality
Monoclonal
Clone ID
B-F43
Myeloma
Source: Recombinant antibody from the original clone
Isotype
Mouse IgG1 Kappa light chain
Conjugate

Biotin

Concentration
0.1 mg/mL (+/- 10 %)
Product Form
Liquid
Formulation
Phosphate-buffered saline with 1% BSA and 0.09% sodium azide.
Storage
Store at + 4°C. Stable for 12 months..
Intended Use
The suggested coating concentration range below should be optimised by each laboratory for each application. ELISA: 0,05-0,5µg/ml
General Notes
For bulk or custom IVD raw material requests, contact us directly.

IVD reagents are supplied in accordance with standard industry lead times of 4-6 weeks. Where products are in stock, dispatch typically occurs within 7-10 business days.
Synonyms
FIL1 zeta, FIL1Z, IL-1 zeta, IL-1H, IL-1H4, IL-1RP1, IL-1X, IL-37, IL1F7, IL1H4, IL1RP1, IL37, Interleukin-1 family member 7, Interleukin-1 homolog 4, Interleukin-1 zeta, Interleukin-1-related protein, Interleukin-37
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Recombinant Anti-IL-1F7 Antibody [B-F43] (Biotin) (A342236)? Please let us know so that we can list the citation on this page.

Proteins predicted to interact with IL-1F7

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
98% Relevancy Score
97% Relevancy Score
96.5% Relevancy Score
95.6% Relevancy Score
94.7% Relevancy Score
94.3% Relevancy Score
85.2% Relevancy Score
80.7% Relevancy Score